| Literature DB >> 35806989 |
Jakub Klimkiewicz1, Anna Klimkiewicz2, Mateusz Gutowski1, Bartosz Rustecki1, Dymitr Kochanowski1, Robert Ryczek3, Arkadiusz Lubas4.
Abstract
INTRODUCTION: Intertrochanteric fracture (IF) is a common injury among the elderly. Due to significant comorbidities, anesthesia for IF repair may be challenging. The authors propose femoral nerve block together with a lateral femoral cutaneous nerve block and sedation as an anesthetic technique for most severe cases of IF with contraindications to spinal anesthesia.Entities:
Keywords: femoral nerve block; intertrochanteric fracture; lateral femoral cutaneous nerve block
Year: 2022 PMID: 35806989 PMCID: PMC9267460 DOI: 10.3390/jcm11133708
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Descriptive statistics.
| Variable | Mean ±SD or |
|---|---|
| Age (years) | 86 [65; 97] |
| Hemoglobin (g/L) | 11.9 ±1.8 |
| eGFR (ml/min) | 90 [24; 90] |
| ASA | 3 [2; 4] |
| NHFS | 6 [1; 8] |
| CCI | 6 [2; 14] |
| CCI% | 2 [0; 90] |
| Hospital stay after surgery [days] | 7 [2; 60] |
Factors contributing to perioperative risk.
| General Anesthesia | Spinal Anesthesia | Peripheral Nerve Blocks |
| |
|---|---|---|---|---|
| Age (years) | 83 ±7.8; | 84.4 ±8.1; | 87.7 ±5.5; | 0.252 |
| Hemoglobin (g/L) | 12.3 ±1.4; | 12.4 ±1.7; | 11.0 ±2.1; | 0.055 |
| eGFR (ml/min) | 90 [35; 90] | 90 [45; 90] | 50 [24; 90] | 0.086 |
| ASA | 3 [2; 4] | 3 [2; 4] | 4 [2; 4] | <0.001 |
| NHFS | 5.3 ±1.6; | 5.1 ±0.9; | 6.6 ±1.1; | <0.001 |
| CCI | 5.8 ±3.0; | 6.0 ±1.9; | 7.4 ±0.9; | 0.002 |
| CCI% | 21 [0; 90] | 2 [0; 90] | 0 [0; 2] | 0.012 |
|
|
|
|
| |
| Gender (Male/Female) | 6/13 | 4/18 | 5 (25%) | 0.609 |
| Dependency | 3 (15.8%) | 2 (9.1%) | 2 (10%) | 0.773 |
| Diabetes | 3 (15.8%) | 2 (9.1%) | 2 (10%) | 0.573 |
| Obesity BMI > 30 yes | 2 (10.6%) | 1 (4.5%) | 2 (10%) | 0.735 |
| Underweight BMI <18.5 yes | 1 (5.3%) | 0 | 0 | 0.325 |
| Cardiovascular and cerebrovascular incidents in past | 8 (42.1%) | 11 (50%) | 15 (75%) | 0.093 |
| Active malignancy | 4 (21.1%) | 0 | 1 (5%) | 0.041 |
| Malignancy in last 20 years | 0 | 1 (4.5%) | 1 (5%) | 0.624 |
| Dementia | 6 (31.6%) | 7 (31.8%) | 10 (50%) | 0.383 |
| Heart failure | 10 (52.6%) | 14 (63.6%) | 18 (90%) | 0.033 |
| COPD | 3 (15.8%) | 1 (4.5%) | 2 (10%) | 0.483 |
| Frailty | 9 (47.4%) | 16 (72.7%) | 11 (55%) | 0.233 |
| More than 2 comorbidities | 16 (84.2%) | 18 (81.8%) | 20 (100%) | 0.141 |
| More than 4 medications | 14 (73.7%) | 19 (86.2%) | 20 (100%) | 0.052 |
| Hemostasis disorders | 18 (94.7%) | 22 (100%) | 10 (50%) | <0.001 |
| Hemoglobin < 10 g/dL | 3 (15.8%) | 1 (4.5%) | 10 (50%) | 0.001 |
| eGFR <30 mL/min | 0 | 0 | 3 (15%) | 0.039 |
Results of the treatment.
| General Anesthesia ( | Spinal Anesthesia | Peripheral Nerve Blocks ( |
| |
|---|---|---|---|---|
| Death | 1 (5.3%) | 2 (9.1%) | 1 (5%) | 0.835 |
| Cardiovascular and cerebrovascular events after surgery | 0 | 3 (13.6%) | 2 (10%) | 0.266 |
| Loss of independence | 2 (10.6%) | 5 (26.3%) | 5 (25%) | 0.427 |
| Delirium | 10 (52.6%) | 9 (41%) | 10 (50%) | 0.728 |
| Hospital stay after surgery [days] | 7 [5; 9] | 7.5 [4; 60] | 8 [2; 50] | 0.153 |